Hoyle, AP; Ali, A; James, ND; Cook, A; Parker, CC; de Bono, JS; Attard, G; ... STAMPEDE Investigators; + view all (2019) Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. European Urology , 76 (6) pp. 719-728. 10.1016/j.eururo.2019.08.006. Green open access